Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Talc Pleurodesis vs. Indwelling Pleural Catheter for MPE
NCT02825095Phase 1Unknown
- Sponsor
- Rambam Health Care Campus
- Start
- Aug 2016
- Primary completion
- May 2017
01
Overview
Phase 1, randomised, open-label trial in malignant pleural effusion (MPE), sponsored by Rambam Health Care Campus. Primary endpoint: Quality of Life at 12 months. Status: unknown.
02
Conditions
malignant pleural effusion (MPE)
Beyond the preview
Go deeper on NCT02825095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02825095.